SS-31 (Elamipretide) is a mitochondria-targeting peptide that binds to cardiolipin in the inner mitochondrial membrane, increasing ATP production, reducing reactive oxygen species (ROS), and preventing apoptosis. It offers significant benefits for reversing age-related mitochondrial dysfunction, improving cardiovascular, renal, and skeletal muscle health, and providing neuroprotection.
Key benefits of SS-31 peptide include:
- Enhanced Energy Production: Increases ATP supply and improves mitochondrial electron transport chain efficiency.
- Mitochondrial Protection & Repair: Reduces excessive mitochondrial fragmentation, stabilizes mitochondrial cristae, and protects against ROS-induced damage.
- Cardiovascular Support: Improves left ventricular ejection fraction (LVEF), reduces cardiac hypertrophy, and alleviates pressure overload-induced heart failure.
- Anti-Aging & Metabolic Health: Reverses deficits in mitochondrial energetics in aged tissues, reduces age-related glomerulosclerosis, and improves insulin resistance.
- Neuroprotection: Protects neurons in neurodegenerative models (e.g., Alzheimer’s, Parkinson’s) by reducing mitochondrial dysfunction.
Anti-Inflammatory & Antifibrotic Effects: Reduces oxidative stress-related inflammation and fibrosis.
SS-31 is being researched for potential applications in treating conditions like heart failure, chronic kidney disease, metabolic syndrome, and neurodegenerative disorders.
